Ryohei Ogawa Selected Research

Ryohei Ogawa Research Topics

Disease

19	Neoplasms (Cancer) 03/2021 - 04/2002
10	Lymphoma (Lymphomas) 07/2016 - 02/2003
8	Hyperthermia 01/2019 - 04/2002
4	Leukemia 12/2018 - 02/2004
4	Prostatic Neoplasms (Prostate Cancer) 07/2013 - 05/2007
2	Malaria 11/2021 - 10/2018
2	Hypoxia (Hypoxemia) 08/2015 - 05/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2014 - 01/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2009 - 06/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2002 - 01/2002
1	Necrosis 03/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2018
1	Osteosarcoma (Osteogenic Sarcoma) 06/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2010
1	Muscle Hypotonia (Hypotonia) 01/2010
1	Colonic Neoplasms (Colon Cancer) 01/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2006

Drug/Important Bio-Agent (IBA)

6	LuciferasesIBA 03/2021 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2019 - 06/2009
4	CaspasesIBA 05/2014 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2006
3	SuspensionsIBA 01/2010 - 04/2002
3	Complementary DNA (cDNA)IBA 01/2009 - 03/2006
3	SHU 508 (Levovist)IBA 06/2008 - 02/2003
3	Free RadicalsIBA 01/2007 - 06/2003
3	2,2'-azobis(2-amidinopropane) (ABAP)IBA 01/2007 - 06/2003
2	SolutionsIBA 12/2018 - 02/2004
2	CadmiumIBA 02/2018 - 12/2011
2	Docosahexaenoic AcidsIBA 08/2015 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 01/2013
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 06/2010 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 01/2010
2	LigandsIBA 06/2010 - 01/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009 - 04/2008
2	2-amino-4-hydroxy-6-formylpteridineIBA 01/2007 - 04/2004
2	Contrast MediaIBA 10/2006 - 02/2003
1	Biological ProductsIBA 11/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2019
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2019
1	Glutathione (Reduced Glutathione)IBA 12/2018
1	hydroxide ionIBA 12/2018
1	Cystine (L-Cystine)IBA 12/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2018
1	AntiportersIBA 12/2018
1	Glutamic Acid (Glutamate)FDA Link 12/2018
1	VaccinesIBA 10/2018
1	PlatinumIBA 07/2016
1	tempolIBA 08/2015
1	Oxygen (Dioxygen)IBA 08/2015
1	nitroxylIBA 08/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Protein Kinase CIBA 05/2014
1	nutlin 3IBA 01/2010
1	Heme Oxygenase-1IBA 01/2009
1	phenyl-N-tert-butylnitroneIBA 01/2007
1	Liposomes (Liposome)IBA 10/2006
1	Trypan Blue FDA Link 03/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	Coloring Agents (Dyes)IBA 03/2006
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2006
1	EBV-encoded nuclear antigen 1IBA 01/2006
1	chromium hexavalent ionIBA 06/2004
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2004
1	Phosphates (Orthophosphate)IBA 02/2004
1	Cytochromes c (Cytochrome c)IBA 06/2003
1	FS 069 (Optison)FDA Link 02/2003
1	Local AnestheticsIBA 05/2002
1	Lidocaine (Xylocaine)FDA LinkGeneric 05/2002
1	Superoxides (Superoxide)IBA 05/2002
1	Adenosine Triphosphate (ATP)IBA 05/2002
1	Caspase 3 (Caspase-3)IBA 05/2002

Therapy/Procedure

13	Therapeutics 03/2021 - 04/2002
5	Induced Hyperthermia (Thermotherapy) 05/2014 - 04/2002
1	Radiotherapy 05/2015
1	Drug Therapy (Chemotherapy) 06/2010
1	Microbubbles 06/2008